Joslin Diabetes Center President and CEO Ranch C. Kimball to Step Down
BOSTON May 29, 2009 Joslin Diabetes Center, the worlds preeminent diabetes research and clinical care organization, announced today that its President and CEO Ranch C. Kimball will step down by the end of August. Kimball has been widely credited with improving the overall health and fiscal stability of the world-renowned organization.
Appointed in February 2007, Kimball, who previously served as Secretary of Economic Development for the Commonwealth of Massachusetts, was charged with expanding philanthropic giving to the Joslin, completing the sale of a Joslin-owned real estate parcel, improving Joslins fiscal stability and raising Joslins visibility in the community.
The Board of Trustees and I are pleased that Ranch achieved our strategic goals which, when combined, have put Joslin on solid footing for our future, said Kevin E. Conley, Chairman of the Board of Trustees. Under Kimballs leadership, philanthropic giving expanded dramatically with record giving in 2008, we completed the sale of a strategic real estate parcel, raising important revenue, Joslins financial position was solidified, and the Joslins visibility is significantly enhanced. We are extremely grateful to Ranch for his tremendous work to strengthen this vital institution.
Kimball also led a strategic planning process to identify a long-term vision for the Joslin. That process contributed to Kimballs decision to step down.
As part of our strategic planning process, it became clear that the next step for the Joslin is to further refine its scientific and medical agenda, said Kimball. I believe those goals are best achieved by a leader with a different background and experience. I am honored by the opportunity to have contributed to the important work of the Joslin.
Kimball will work with the Board of Trustees through August to support a search for his successor. Trustees and colleagues praised Kimball for his management ability and his commitment to the Centers health care mission.
Ranch was exactly the President and CEO we needed at the time, and he set the stage for the next phase of the Joslin, said John Brooks, Trustee and Finance Chair of the Center. His willingness to work alongside the Board while we restructure leadership around our medical and scientific programs is welcome, and we will miss him.
Ranch did a great job understanding the clinical and scientific issues in diabetes. Wed always see him walking through the halls in Clinic, asking doctors and nurses what was working, what wasnt, and about patient care, said Howard Wolpert, M.D., Director of the Insulin Pump program at Joslin and member of the Board of Trustees. He brought a level of passion and commitment to our clinical care model for diabetes treatment.
In addition to his service in the Romney administration, Kimball is one of Bostons most respected and well-known leaders. He serves on the boards of the Mass Business Roundtable, and Boston World Partnerships. He is Chair of the Board of Overseers of the Museum of Science, and Vice Chair of the Board of MassPort, where he also chairs the audit and finance committees. He was previously managing partner of private equity firm Kissinger McLarty Capital Group, and a long-time partner at Boston Consulting Group.
Courtesy of Joslin Diabetes Center
Roasted Garlic Spicy Stuffed Potato Skins Sweet Curry Chicken Spinach Florentine Italiano Turkey Pita Pizzazz Chicken Flavored Nachos Mussels and Tomatoes in Wine Sauce Baked Tuna Macaroni and Cheese Mini Cheesecakes Crispy Oriental Pizza
As I mentioned in an earlier post, one of the benefits that made it cost-effective for me to go with the real healthcare (HSA) plan rather than the phony (HRA) plan is that my company is now covering "preventative" medicines at $0 copay. The formulary for these, as stated by CVS/Caremark (my pharmacy benefits provider), covers all test strips, lancets, and control solutions. I dutifully get my doctor to write up prescriptions for all of my testing needs, submit...